News

Exclusive: Trump administration banned chosen names at FDA, CDC, NIH under new gender policy
Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...
FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
COVID vaccine boosters called into question by FDA chief: ‘Void of data’
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
US FDA approves J&J's immune disorder drug
The U.S. Food and Drug Administration has approved Johnson & Johnson's drug to treat some patients aged 12 years and older ...
Bread Recalled Over 'Glass Fragments' as FDA Warns Consumption Could Cause 'Adverse Health Consequences'
Bread and rolls sold in six states have been recalled over 'glass fragments,' according to the U.S. Food and Drug ...
STAT21h
Will the FDA approve the first new drug to help people quit smoking in 20 years?
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...
FDA looking to ban petroleum-based synthetic dyes from foods, Virginia Tech expert shares thoughts
BLACKSBURG, Va. (WDBJ) - Earlier this year, the Food and Drug Administration (FDA) banned the use of Red No.3 dye. This is ...
Omaha bakery concerned over FDA’s potential ban of certain food dyes
The Food and Drug Administration is attempting to phase out petroleum-based synthetic blue, red, yellow, green dyes in favor ...
Medscape9h
FDA Approves New Monoclonal Antibody for Myasthenia Gravis
The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.
BioPharma Dive13h
J&J secures FDA OK for immune drug touted as future blockbuster
The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...
STAT1d
Amid FDA chaos, approval of a rare disease drug gets delayed — again
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
FDA says it will phase out petroleum-based food dyes, authorize four natural color additives
The US Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to ...